Novartis India shines on planning to buyback equity shares

21 Sep 2017 Evaluate

Novartis India is currently trading at Rs. 679.05, up by 30.25 points or 4.66% from its previous closing of Rs. 648.80 on the BSE.

The scrip opened at Rs. 690.00 and has touched a high and low of Rs. 697.30 and Rs. 675.10 respectively. So far 137242 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 758.00 on 18-Apr-2017 and a 52 week low of Rs. 579.00 on 11-Aug-2017.

Last one week high and low of the scrip stood at Rs. 697.30 and Rs. 617.20 respectively. The current market cap of the company is Rs. 1907.24 crore.

The promoters holding in the company stood at 73.40%, while institutions and non-institutions held 1.33% and 25.27% respectively.

Novartis India is planning for buyback of its equity shares. The meeting of the Board of Directors of the Company will be held on September 25, 2017, to consider the same proposal, constitution of buyback committee, and appointment of intermediaries in accordance with all applicable provisions of law.

Novartis is a world leader in the research and development of products to protect and improve health and well-being. The company has core businesses in pharmaceuticals, vaccines, consumer health, generics, eye care and animal health.

Novartis Share Price

786.15 0.60 (0.08%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 250.65
Adani Enterprises 1862.80
Amrapali Industries 14.20
Rashi Peripheral 339.00
PDS 311.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×